J B CHEMICALS AND PHARMA

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange details of shares held by the promoters and employees (together with relatives) of the Company as on September 30, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated September 29,2005 titled "J.B.Chemicals receives US FDA approval to market Fluconazole tablets in the US market". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that with reference to the news item appeared in 'The Business Standard' dated August 31, 2005, titled 'JB Chem to buy Russian Firm', the Company denies the said news report as baseless and incorrect. The Company has further stated that the said news item is only a rumour as the Company does not have any acquisition plans in Russia for now. Shri J B Mody, Chairman & Managing Director of the Company has already denied the said news report on CNBC (nationwide) on August 31, 2005 instantly. Further, the Company as a matter of policy ha

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Company has allotted 31125 equity shares of Rs.2/- each to those employees having exercised their options under the Company's ESOS.

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the minutes of the AGM of the Company held on July 14, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that Shri Rohit S Shah has resigned from the Directorship of the Company w.e.f. July 29, 2005.

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a Press Release dated July 28,2005, titled "J.B. Chemicals reports increase in Net Sales and PAT for Q1 ended June 30,2005 - Net Sales up by 33% to Rs.9462.43 lakhs, PAT up by 15% to Rs. 1181.64 lakhs." The details of the Press Release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the AGM of the Company was held on July 14, 2005 where all the business listed in Notice was transacted and resolutions for the same were passed unanimously. The Members of the Company approved declaration of final dividend @ Rs.1.40 (70%) per equity share on a capital of Rs.1605.90 lakhs divided into 8,02,95,000 Equity Shares of Rs.2/- each. The date of payment of dividend will be July 21, 2005.

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated July 12, 2005, titled "'Doktor Mom' brand of J. B. Chemicals once again does India proud in the international market - Now awarded "Superbrand 2005" status in Russia". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange details of shares held by the promoters and employees (together with relatives) of the Company as on June 30, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has issued a press release dated July 05, 2005, titled 'Ranbaxy to market Doktor Mom Herbal brand range of J. B. Chemicals, in Romania'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has issued a press release dated June 22, 2005 titled 'J B Chemicals & Pharmaceuticals strengthens / expands board with two additional Directors'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of AGM to be held on July 14, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the 'Chairman's Letter' dated May 30, 2005, sent to Shareholders of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding the following changes in the Directorship of the Company w.e.f. May 12, 2005: 1) Shri C. J. Mody has resigned from the Directorship of the Company. 2) Shri Rajiv Mody has been appointed as Director of the Company to fill-up casual vacancy caused due to the resignation of Shri C. J. Mody. 3) Shri Rohan Singh has been appointed as additional Director of the Company.

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors at their meeting held on May 12, 2005 have recommended a Final Dividend of Rs.1.40 (70%) per Equity Share on a capital of Rs.1605.90 lakhs divided into 8,02,95,000 Equity Shares of Rs.2/- each. After considering the Interim Dividend of 50% already paid, the total dividend for FY 2004-05 works out to 120%.The Register of Members and Share Transfer Books will remain closed from July 04, 2005 to July 14, 2005 (both days inclusive) for ascertaining the Members who are entitled for payment of Final Dividend 20

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has issued a press release dated May 12,2005 featuring the audited results of the company for the year ended March 31,2005. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Company has issued a press release dated May 02, 2005, titled 'J. B. Chemicals forays into Kangaroo (Australian) Country. Signs agreement with Pharm-a-Care, Australia for development and supply of products-Move to further enhance Company's presence in Australian and other international markets'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange the minutes of the proceedings held on March 24, 2005 relating to declaration of results of voting by Postal Ballot. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange the details of shares held by the promoters and employees (together with relatives) of the company as of March 31, 2005. The company has informed that there is an inter-se transfer of 50,000 equity shares (0.31%) among relatives by way of Gift. (i.e. Transfer of 25,000 shares each to Priti S. Mody (Daughter) and Nirav S. Mody (Son) from S. B. Mody's (Father) account. Other than that, there is no change in the shareholding or voting rights exceeding Rupees Five Lakhs in value or 5000 shares or 2% of total shareholding or voting r

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the exchange a specimen copy of the letter sent to Shareholders of the company in connection with sub-division of shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements)

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that Results of the voting conducted through Postal Ballot on March 24,2005 are as follows: Resolution 1 Ordinary Resolution under section 94(1)(d) of the Companies Act, 1956 for sub-division of 1 equity share of having a nominal value of Rs. 10/- each into 5 equity shares having a nominal value of Rs. 2/- each. a) Total Postal Ballot received:- 2276 Postal Ballot & 10221828 Shares; b) Less : Invalid Postal Ballots:- 179 Postal Ballot & 172478 Shares; c) Net valid Postal Ballots:- 2097 Postal Ballot & 10049350 Shares; d) Assent for

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has fixed April 12, 2005 as the record date for the purpose of sub-division of 1 (one) equity share having a nominal value of Rs. 10/- into 5 (five) equity shares having a nominal value of Rs. 2/- each.

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Company has issued a press release dated March 17, 2005, titled 'J. B. Chem's 'Doktor Mom' is most trusted European Brand 2005 - Receives Award from Readers Digest for Fifth Successive Year.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Company has issued a press release dated February 24, 2005, titled "TGA, Australia approves J. B. Chemicals Tablets Manufacturing Facility at Panoli - Approval further opens huge international market for company". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956,read with the Companies(passing of the resolution by Postal Ballot)Rules,2001 the following two resolutions recommended by the BODs of the company at their meeting held on January 27,2005 subject to the approval of the shareholders are proposed to be passed as an Ordinary and Special Resolution respectively by way of postal ballot:1)Sub-division of 1 equity share having a nominal value of Rs.10/- each into 5 equity shares having a nominal value of Rs.2/- each by passing an ord

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has issued a press release dated February 10, 2005 titled 'Renowned International Cardiologist Prof. Dr. Philip A. Poole Wilson Shares Findings Of Trials On Anti Anginal Drugs - Nifedipine GITS (Sustained Release) Emerges As The Best Anti-Anginal Drug.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that BoDs at their meeting held on January 27, 2005 have recommended sub-division of the nominal value of the share from Rs.10/- to Rs.2/- each, subject to the approval of the shareholders in an appropriate manner.

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has issued a press release dated January 27, 2005 titled 'J.B Chemicals reports increase in turnover and Net Profit for the Q3 ended December 31, 2004.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange the details of shares held by the promoters and employees (together with relatives) of the company as of December 31, 2004 and of September 30, 2004 respectively. The company has further intimated that there is no change in the shareholding or voting rights exceeding Rupees Five Lakhs in value or 5000 shares or 2% of total shareholding or voting rights, whichever is lower. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange the details of shares held by the promoters and employees (together with relatives) of the company as of September 30,2004 and June 30,2004.The company has further intimated that there is no change in the shareholding or voting rights exceeding Rupees Five Lakhs in value or 5000 shares or 2% of total shareholding or voting rights, whichever is lower. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnounc

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has on December 08,2004 issued a press release titled "US FDA ACCEPTS JBCPL'S USDMF FOR CIPROFLOXACIN HYDROCHLORIDE(API)".The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has issued a press release on November 08,2004 titled "J.B.Chemicals launches Magnilek, A MRI CONTRAST media, Expanding High-Tech Diagnostic Product Range." The details of the press release issued by the Company shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

JB Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has on November 03, 2004 issued a press release titled "JB Chemicals to Foray into Bio-Technology". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the BOD have at their meeting held on October 28, 2004, recommended an Interim Dividend of Rs.5.00 (50%) per equity share, on equity shares of Rs.10/- each for the FY 2004-05. The Company has announced November 16, 2004 as the Record Date for the purpose of payment of interim dividend of Rs.5.00 (50%) per share of Rs.10/- each, for the FY 2004-05.

JB Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has issued a press release titled "JB Chemicals & Pharmaceuticals appoints Mr. Jay Mehta as Vice President, R&D to enhance Research & Development activities". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Clarification of News : The press had reports that JB Chemicals & Pharmaceuticals Limited is planning a bonus issue for its shareholders. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. JB Chemicals & Pharmaceuticals Ltd. has vide its letter inter-alia stated, "We deny the said news report as baseless and incorrect. The said news item is only a rumour, as the Company does not have any plans to announce bonus in th